Status:

COMPLETED

The Effect of NSAID Steroid Therapy for PGE2 Level and Analgesia After Percutaneous Nephrolithotomy Surgery

Lead Sponsor:

Universitas Jenderal Soedirman

Conditions:

Percutaneous Nephrolithotomy (PCNL)

Postoperative Pain

Eligibility:

All Genders

18-70 years

Phase:

PHASE4

Brief Summary

The goal of this clinical trial is to learn if combination of NSAID-steroid can decrease the PGE2 level and postoperative pain after percutaneous nephrolithotomy surgery. It will also learn about the ...

Detailed Description

Our study aim to investigate the effect of NSAID steroid therapy to PGE2 level and analgesia after percutaneous nephrolithotomy surgery. This study is a double blind randomized controlled trial at a p...

Eligibility Criteria

Inclusion

  • Elective, percutaneous nephrolithotomy surgery
  • Age ≥ 18 years to ≤ 70 years
  • Body mass index (BMI) \> 18 kg/m2 to \< 40 kg/m2
  • American Society of Anesthesiologists (ASA) Physical Status Classification System 1-3.
  • Written informed consent to participate in the trial.

Exclusion

  • Patients with allergy to ibuprofen, paracetamol, and dexamethasone
  • Patients with uncontrolled diabetes mellitus
  • Patients with previous history of alcohol or drug abuse
  • Patients who unconscious
  • Patients with neurological disorders
  • Patients with cognitive impairment
  • Patients who incapable of communication
  • Patients with daily use of systemic glucocorticoids within 3 months prior to surgery
  • Patients with daily use of high-dose opioid (tramadol 150 mg/day or morphine \>30 mg/day orally) or use transdermal opioid
  • Patients who are contraindicated to ibuprofen or paracetamol, include a history of peptic ulcers, renal failure (glomerular filtration rate \<60 ml/kg/1.73 m2), heart failure, severe liver dysfunction, thrombocytopenia \<100,000/L.

Key Trial Info

Start Date :

October 8 2024

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 8 2024

Estimated Enrollment :

45 Patients enrolled

Trial Details

Trial ID

NCT06604598

Start Date

October 8 2024

End Date

November 8 2024

Last Update

November 12 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Margono Soekarjo Hospital

Banyumas, Central Java, Indonesia, 53146